Biotin anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
a-N418_A_Biotin_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • a-N418_A_Biotin_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • b-N418_B_Biotin_Neg_071006
  • c-N418_Biotin_CD11c_Antibody_3_012621
    Frozen mouse spleen sections. Endogenous biotin blocking applied prior to incubation of primary antibody anti‐mouse CD11c biotin followed by secondary detection with Alexa Fluor® 555 streptavidin. Images were acquired with an automated widefield microscope (Nikon Eclipse Ti) and a CCD camera (QImaging Retiga 2000R). Images provided by Ann Haberman and Tingting Zhang, Yale University.
Compare all formats
Cat # Size Price Quantity Check Availability Save
117303 50 µg 62€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117304 500 µg 212€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kellermayer Z, et al. 2019. J Immunol. 202:1833. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  4. Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed
  5. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  6. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  7. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  8. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  9. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  10. Palumbo R, et al. 2012. J Control Release. 159:232. PubMed
  11. Hu Z, et al. 2015. J Exp Med. 101084/jm20150178. PubMed
  12. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  13. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  14. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  15. Stone MB et al. 2017. eLife. 6 pii: e19891. PubMed
  16. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  17. Mori T, et al. 2014. J Immunol. 193:1728. PubMed
  18. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  19. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  20. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  21. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  22. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  23. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  24. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  25. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  26. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  27. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  28. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  29. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  30. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  31. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  32. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  33. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  34. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  35. Köchl R, et al. 2020. Elife. 9:00. PubMed
  36. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  37. Yang Z et al. 2016. eLife. 5 pii: e21238. PubMed
  38. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  39. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  40. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  41. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  42. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  43. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  44. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  45. Jawhara S, et al. 2012. J Immunol. 189:2468. PubMed
  46. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  47. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  48. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  49. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  50. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  51. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  52. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  53. Cheng Q, et al. 2014. J Immunol. 192:3686. PubMed
  54. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  55. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  56. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  57. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  58. Baptista A, et al. 2014. Elife. 3:4433. PubMed
  59. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  60. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  61. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  62. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  63. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  64. Hu G, et al. 2018. Immunity. 48:227. PubMed
  65. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  66. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  67. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  68. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  69. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  70. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  71. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  72. Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
  73. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  74. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  75. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  76. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  77. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  78. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  79. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_313772 (BioLegend Cat. No. 117303)
AB_313773 (BioLegend Cat. No. 117304)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Go To Top Version: 4    Revision Date: 01-26-2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account